List of Wakix drug patents

Wakix is owned by Harmony.

Wakix contains Pitolisant Hydrochloride.

Wakix has a total of 3 drug patents out of which 0 drug patents have expired.

Wakix was authorised for market use on 14 August, 2019.

Wakix is available in tablet;oral dosage forms.

Wakix can be used as method of treating excessive daytime sleepiness in patients with narcolepsy; method of treating cataplexy in patients with narcolepsy.

Drug patent challenges can be filed against Wakix from August, 2023.

The generics of Wakix are possible to be released after 07 March, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8207197 HARMONY Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine
Mar, 2030

(7 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8354430 HARMONY Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine
Feb, 2026

(3 years from now)

US8486947 HARMONY Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3-receptor ligands
Sep, 2029

(6 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Aug 14, 2024
Orphan Drug Exclusivity (ODE) Oct 13, 2027
New Indication (I) Oct 13, 2023

Drugs and Companies using PITOLISANT HYDROCHLORIDE ingredient

NCE-1 date: August, 2023

Market Authorisation Date: 14 August, 2019

Treatment: Method of treating excessive daytime sleepiness in patients with narcolepsy; Method of treating cataplexy in patients with narcolepsy

Dosage: TABLET;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic